International Association For The Study Of Lung Cancer company information, Employees & Contact Information

New Grading System for Invasive Squamous Cell Carcinoma of the Lung – IASLC Oncodaily

New Grading System Proposed for Invasive Lung Squamous Cell Carcinoma in Journal of Thoracic Oncology Study Bioengineer.org

New Research aimed at Predicting Which Lung Cancer Patients GlobeNewswire

FLAURA2 Trial Demonstrates Enhanced Overall Survival with Osimertinib and Bioengineer.org

Excited to Announce the 2025 Board of Directors – IASLC Oncodaily

New CEO of IASLC: ‘It’s important to take new opportunities’ Healio

Lung Cancer Research Foundation and the International Association for the Study of Lung Cancer (IASLC) Announce New Research Partnership PR Newswire

IASLC Launches New Education Center--Lung Cancer 360 A New Platform for Online Multidisciplinary Learning Activities PRWeb

Phase 2 IDeate-Lung01 Trial Shows Ifinatamab Deruxtecan Achieves High Bioengineer.org

Top 10 OncoGrants of the Week: Major Global Cancer Research Funding Calls Oncodaily

UK Study Finds Lung Cancer Screening Benefits Adults Up to Age 80 Who Are Surgical Candidates Bioengineer.org

Helena Linardou: Last Chance to Vote for the IASLC Board Election by May 22 Oncodaily

New Study Reveals Circulating Tumor DNA Could Guide Immunotherapy in Limited-Stage SCLC Bioengineer.org

The 2025 IASLC World Conference on Lung Cancer Oncodaily

The IASLC’s Hot Topic in Basic and Translational Science: SCLC has extended the abstract submission deadline Oncodaily

Stephen V Liu: The FDA Approved CheckMate 77T regimen for resectable NSCLC Oncodaily

The IASLC Academy is accepting applications from early career professionals in Thoracic Oncology Oncodaily

2024 IASLC Distinguished Service Awards Recipients Oncodaily

Congratulations to the 2024 Jen Brock Memorial Award recipient, Dr. Dinh Thi Lan Anh Oncodaily

International Association for the Study of Lung Cancer (IASLC) and Lung Cancer Research Foundation (LCRF) Announce Request for Proposals PRWeb

TOGA Welcomes Emily Stone as the New Chair of the Board of Directors Oncodaily

World Conference on Lung Cancer 2026 Oncodaily

Normalized membrane ratio of TROP2 by quantitative continuous scoring predictive of clinical outcomes in TROPION-Lung 01 EurekAlert!

WCLC 2025: DLL3 Therapy Shows Promise in Relapsed SCLC European Medical Journal

Combination extends survival in extensive-stage small cell lung cancer Healio

COMPEL Study Finds Adding Chemotherapy to Osimertinib After Progression Bioengineer.org

Continuing Osimertinib Plus Chemo After Progression Improves PFS in EGFR-Mutated NSCLC OncLive

WCLC 2025: IFITM3 May Improve Immunotherapy Outcomes in SCLC European Medical Journal

AEGEAN Update Confirms Benefit of Perioperative Durvalumab in Resectable NSCLC The ASCO Post

2019 World Conference Of Lung Cancer Round-Up CancerNetwork

CheckMate 77T: Nivolumab Preserves Quality of Life and Mitigates Symptom Worsening in Resectable NSCLC Bioengineer.org

Tarlatamab Combined with Anti-PD-L1 Shows Promising Safety and Bioengineer.org

NADIM II trial provides further support for neoadjuvant chemoimmunotherapy for patients with resectable non-small cell lung cancer EurekAlert!

A pretreatment prediction model of grade 3 tumors classed by the IASLC grading system in lung adenocarcinoma BMC Pulmonary Medicine

NELSON trial protocol more sensitive than NLST and may increase the benefits of lung cancer screening, while reducing unnecessary follow-up procedures EurekAlert!

Study Confirms Accuracy of AI Lung Cancer Risk Model Sybil in Predominantly Bioengineer.org

Ivonescimab Combined with Chemotherapy Enhances Progression-Free Survival Bioengineer.org

EA5181 Phase 3 Trial Shows No Overall Survival Advantage for Concurrent Bioengineer.org

IASLC North America: Lung Cancer Screening Among First Responders The ASCO Post

The storm of NGS in NSCLC diagnostic-therapeutic pathway: How to sun the real clinical practice ScienceDirect.com

Phase II Study Finds Iza-Bren Plus Osimertinib Achieves 100% Response Rate in EGFR-Mutated NSCLC Bioengineer.org

Novel Antibody-Drug Conjugate Demonstrates Promising Efficacy in EGFR-Mutated NSCLC Patients Bioengineer.org

Phase III Trial Shows Hypofractionated Radiotherapy Plus Chemotherapy Bioengineer.org

Daan Padmos Obituary - Montrose, NY Dignity Memorial

WCLC 2019: Final Overall Survival Results of IMpower131 Trial in Advanced Squamous NSCLC The ASCO Post

FANSS Study Validates Feasibility of Lung Cancer Screening for Asian Female Nonsmokers in the U.S. Bioengineer.org

BMS-986504 Shows Lasting Efficacy in MTAP-Deleted NSCLC, Targeting EGFR and ALK-Positive Tumors Bioengineer.org

The IASLC Lung Cancer Staging Project: Proposals for Coding T Categories for Subsolid Nodules and Assessment of Tumor Size in Part-Solid Tumors in the Forthcoming Eighth Edition of the TNM Classification of Lung Cancer ScienceDirect.com

International Association for the Study of Lung Cancer (IASLC) Lymph Node Map: Radiologic Review with CT Illustration RSNA Journals

IASLC/ITMIG Staging System and Lymph Node Map for Thymic Epithelial Neoplasms | RadioGraphics RSNA Journals

Howard Tisch Obituary (1939 - 2020) - Sarasota, FL - Herald Tribune Legacy obituary

HOWARD TISCH Obituary (1939 - 2020) - Sarasota, FL - New York Times Legacy obituary

International lung cancer experts seek public comments on revised molecular testing guideline Medical Xpress

Genetic Composition of Multicentric Lung Tumors Appears to be Similar | Newswise Newswise

Mark Pearl Obituary (1956 - 2020) - Middletown, Md, MD - The Frederick News-Post Legacy obituary

Anna Lino Obituary - North Palm Beach, FL Dignity Memorial

Filipino receives IASLC fellowship award to find new therapies for lung cancers Inquirer.net

CUHK Receives an International Cancer Care Team Award Nominated by Patients - Press Releases - News The Chinese University of Hong Kong

CUHK Receives an International Cancer Care Team Award Nominated by Patients CUHK Communications and Public Relations Office